These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Thrombotic microangiopathy after GVHD prophylaxis with tacrolimus/sirolimus: a call for use of consensus definition in reporting. Kharfan-Dabaja MA; Pidala J; Anasetti C Blood; 2010 May; 115(21):4316-7; author reply 4317. PubMed ID: 20508174 [No Abstract] [Full Text] [Related]
3. Eculizumab for drug-induced de novo posttransplantation thrombotic microangiopathy: A case report. Safa K; Logan MS; Batal I; Gabardi S; Rennke HG; Abdi R Clin Nephrol; 2015 Feb; 83(2):125-9. PubMed ID: 24495904 [TBL] [Abstract][Full Text] [Related]
4. De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival. Caires RA; Marques ID; Repizo LP; Sato VA; Carmo LP; Machado DJ; de Paula FJ; Nahas WC; David-Neto E Transplant Proc; 2012 Oct; 44(8):2388-90. PubMed ID: 23026601 [TBL] [Abstract][Full Text] [Related]
5. A case of tacrolimus-associated thrombotic microangiopathy after ABO-blood-type-incompatible renal transplantation. Takeda A; Ohtsuka Y; Horike K; Inaguma D; Goto N; Watarai Y; Uchida K; Morozumi K Clin Transplant; 2011 Jul; 25 Suppl 23():15-8. PubMed ID: 21623908 [TBL] [Abstract][Full Text] [Related]
6. De novo tacrolimus-induced thrombotic microangiopathy in the early stage after renal transplantation successfully treated with conversion to everolimus. Cortina G; Trojer R; Waldegger S; Schneeberger S; Gut N; Hofer J Pediatr Nephrol; 2015 Apr; 30(4):693-7. PubMed ID: 25577332 [TBL] [Abstract][Full Text] [Related]
7. Sirolimus-induced thrombotic microangiopathy in a renal transplant recipient. Barone GW; Gurley BJ; Abul-Ezz SR; Gökden N Am J Kidney Dis; 2003 Jul; 42(1):202-6. PubMed ID: 12830473 [TBL] [Abstract][Full Text] [Related]
8. Successful conversion to belatacept after thrombotic microangiopathy in kidney transplant patients. Koppula S; Yost SE; Sussman A; Bracamonte ER; Kaplan B Clin Transplant; 2013; 27(4):591-7. PubMed ID: 23923969 [TBL] [Abstract][Full Text] [Related]
9. Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Cutler C; Henry NL; Magee C; Li S; Kim HT; Alyea E; Ho V; Lee SJ; Soiffer R; Antin JH Biol Blood Marrow Transplant; 2005 Jul; 11(7):551-7. PubMed ID: 15983555 [TBL] [Abstract][Full Text] [Related]
10. Successful sirolimus rescue in tacrolimus-induced thrombotic microangiopathy after living-related liver transplantation. Czubkowski P; Pawłowska J; Jankowska I; Teisseyre M; Kamińska D; Markiewicz M; Ryżko J Pediatr Transplant; 2012 Sep; 16(6):E261-4. PubMed ID: 22066835 [TBL] [Abstract][Full Text] [Related]
11. Treatment with everolimus is associated with a procoagulant state. Baas MC; Gerdes VE; Ten Berge IJ; Heutinck KM; Florquin S; Meijers JC; Bemelman FJ Thromb Res; 2013 Aug; 132(2):307-11. PubMed ID: 23906938 [TBL] [Abstract][Full Text] [Related]
12. Thrombotic microangiopathy in marginal kidneys after sirolimus use. Pellé G; Xu Y; Khoury N; Mougenot B; Rondeau E Am J Kidney Dis; 2005 Dec; 46(6):1124-8. PubMed ID: 16310579 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis of de novo localized thrombotic microangiopathy by surveillance biopsy. Hastings MC; Wyatt RJ; Ault BH; Jones DP; Lau KK; Gaber AO; Gaber LW Pediatr Nephrol; 2007 May; 22(5):742-6. PubMed ID: 17216252 [TBL] [Abstract][Full Text] [Related]
14. Case report: thrombotic microangiopathy post-intravenous immunoglobulin in the context of BK nephropathy and renal transplantation. Pan FF; Hidayati L; Hughes P; Murugasu A; Masterson R Transplant Proc; 2014; 46(1):278-80. PubMed ID: 24507067 [TBL] [Abstract][Full Text] [Related]
15. Tacrolimus-induced thrombotic microangiopathy: natural history of a severe, acute vasculopathy. Carson JM; Newman ED; Farber JL; Filippone EJ Clin Nephrol; 2012 Jan; 77(1):79-84. PubMed ID: 22185974 [TBL] [Abstract][Full Text] [Related]
16. Everolimus, cyclosporine, and thrombotic microangiopathy: clinical role and preventive tools in renal transplantation. Nava F; Cappelli G; Mori G; Granito M; Magnoni G; Botta C; Solazzo A; Fontana F; Baisi A; Bonucchi D Transplant Proc; 2014 Sep; 46(7):2263-8. PubMed ID: 25242766 [TBL] [Abstract][Full Text] [Related]
17. Collapsing glomerulopathy in a renal transplant recipient: potential molecular mechanisms. Dogan E; Ghanta M; Tanriover B Ann Transplant; 2011; 16(2):113-6. PubMed ID: 21716195 [TBL] [Abstract][Full Text] [Related]